Next report date
Report period
Q1 2024
EPS estimate
—
Revenue estimate
—
−0.1485EUR
−1.87 MEUR
77.06 MEUR
6.98 M
About VITA 34 AG
Sector
Industry
CEO
Jakub Julian Baran
Website
Headquarters
Leipzig
Employees (FY)
745
Founded
2003
ISIN
DE000A0BL849
FIGI
BBG000Q4MXP8
Vita 34 AG engages in the collection, storage, and distribution of cells, tissues, blood, and blood components for the purpose of medical applications. It also engages in the development of products and drugs based on cells, tissues, and blood for medical application. The firm produces and manufactures viral vectors and CAR-T cells. It operates through the Vita 34 and PBKM segments. The company was founded by Eberhard F. Lampeter on April 28, 1997 and is headquartered in Leipzig, Germany.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of V3V is 4.6800 EUR — it has decreased by 2.09% in the past 24 hours. Watch VITA 34 AG stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on SWB exchange VITA 34 AG stocks are traded under the ticker V3V.
VITA 34 AG is going to release the next earnings report on May 31, 2024. Keep track of upcoming events with our Earnings Calendar.
V3V stock is 6.58% volatile and has beta coefficient of −0.03. Track VITA 34 AG stock price on the chart and check out the list of the most volatile stocks — is VITA 34 AG there?
VITA 34 AG revenue for the last quarter amounts to 5.38 M EUR despite the estimated figure of 6.00 M EUR. In the next quarter revenue is expected to reach 5.10 M EUR.
Yes, you can track VITA 34 AG financials in yearly and quarterly reports right on TradingView.
V3V stock has fallen by 2.09% compared to the previous week, the month change is a 2.90% fall, over the last year VITA 34 AG has showed a 33.14% decrease.
V3V net income for the last quarter is 3.69 M EUR, while the quarter before that showed −1.62 M EUR of net income which accounts for 328.08% change. Track more VITA 34 AG financial stats to get the full picture.
Today VITA 34 AG has the market capitalization of 86.11 M, it has increased by 6.19% over the last week.
Like other stocks, V3V shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade VITA 34 AG stock right from TradingView charts — choose your broker and connect to your account.
As of May 3, 2024, the company has 745.00 employees. See our rating of the largest employees — is VITA 34 AG on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So VITA 34 AG technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating VITA 34 AG stock shows the sell signal. See more of VITA 34 AG technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on VITA 34 AG future price: according to them, V3V price has a max estimate of 5.30 EUR and a min estimate of 5.30 EUR. Watch V3V chart and read a more detailed VITA 34 AG stock forecast: see what analysts think of VITA 34 AG and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. VITA 34 AG EBITDA is 4.75 M EUR, and current EBITDA margin is 6.16%. See more stats in VITA 34 AG financial statements.